Published in PLoS One on May 04, 2011
From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PLoS One (2011) 2.99
Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010. PLoS One (2011) 1.65
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. Lancet Infect Dis (2013) 1.39
Tuberculosis management practices by private practitioners in Andhra Pradesh, India. PLoS One (2013) 1.33
The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model. PLoS Med (2014) 1.17
The number of privately treated tuberculosis cases in India: an estimation from drug sales data. Lancet Infect Dis (2016) 1.12
Achieving Systemic and Scalable Private Sector Engagement in Tuberculosis Care and Prevention in Asia. PLoS Med (2015) 1.05
Population-level impact of active tuberculosis case finding in an Asian megacity. PLoS One (2013) 0.95
Market size and sales pattern of tuberculosis drugs in the Philippines. Public Health Action (2013) 0.94
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project. Lancet Infect Dis (2016) 0.92
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption. PLoS One (2012) 0.91
Antibiotic Resistance in India: Drivers and Opportunities for Action. PLoS Med (2016) 0.90
Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study. PLoS One (2014) 0.87
Concern Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol (2013) 0.83
Barriers to completing TB diagnosis in Yemen: services should respond to patients' needs. PLoS One (2014) 0.82
How do private general practitioners manage tuberculosis cases? A survey in eight cities in Indonesia. BMC Res Notes (2015) 0.82
Determining quantitative targets for public funding of tuberculosis research and development. Health Res Policy Syst (2013) 0.80
The dragon and the tiger: realties in the control of tuberculosis. Interdiscip Perspect Infect Dis (2012) 0.78
Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India. PLoS One (2015) 0.78
The case for stronger regulation of private practitioners to control tuberculosis in low- and middle-income countries. BMC Res Notes (2015) 0.77
Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011. Western Pac Surveill Response J (2016) 0.75
The Global Drug Facility as an intervention in the market for tuberculosis drugs. Bull World Health Organ (2015) 0.75
Tuberculosis Notification by Private Sector' Physicians in Tehran. Int J Prev Med (2015) 0.75
Tuberculosis case notification by private practitioners in Pune, India: how well are we doing? Public Health Action (2015) 0.75
Engagement of the private pharmaceutical sector for TB control: rhetoric or reality? J Pharm Policy Pract (2017) 0.75
Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients. BMC Infect Dis (2017) 0.75
Feasibility study of strengthening the public-private partnership for tuberculosis case detection in Bandung City, Indonesia. BMC Res Notes (2017) 0.75
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis (2010) 5.14
Tuberculosis patients and practitioners in private clinics in India. Int J Tuberc Lung Dis (1998) 4.70
International standards for tuberculosis care. Lancet Infect Dis (2006) 4.67
Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? PLoS One (2010) 3.67
Improving tuberculosis control through public-private collaboration in India: literature review. BMJ (2006) 3.19
MDR tuberculosis--critical steps for prevention and control. N Engl J Med (2010) 2.49
Treatment of tuberculosis by private general practitioners in India. Tubercle (1991) 2.03
Involving private health care providers in delivery of TB care: global strategy. Tuberculosis (Edinb) (2003) 1.88
Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. Int J Tuberc Lung Dis (2009) 1.76
Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment? BMC Public Health (2010) 1.60
Public-private mix for DOTS implementation: what makes it work? Bull World Health Organ (2004) 1.46
Hard gains through soft contracts: productive engagement of private providers in tuberculosis control. Bull World Health Organ (2006) 1.39
Treatment results among tuberculosis patients treated by private lung specialists involved in a public-private mix project in Vietnam. Int J Tuberc Lung Dis (2003) 1.36
Model collaboration between hospitals and public health system to improve tuberculosis control in China. Int J Tuberc Lung Dis (2009) 1.33
Impact of advocacy on the tuberculosis management practices of private practitioners in Chennai City, India. Int J Tuberc Lung Dis (2009) 1.15
Public-private mix DOTS in the Philippines. Tuberculosis (Edinb) (2003) 1.14
Perceptions of tuberculosis patients about private providers before and after implementation of Revised National Tuberculosis Control Programme. Indian J Tuberc (2009) 1.05
Private practitioners and tuberculosis control in the Philippines: strangers when they meet? Trop Med Int Health (2003) 1.05
Public private mix model in enhancing tuberculosis case detection in District Thatta, Sindh, Pakistan. J Pak Med Assoc (2009) 1.04
Tuberculosis regimen change in high-burden countries. Int J Tuberc Lung Dis (2010) 1.03
Implications of the current tuberculosis treatment landscape for future regimen change. Int J Tuberc Lung Dis (2011) 1.01
Estimating the market for tuberculosis drugs in industrialized and developing nations. Int J Tuberc Lung Dis (2008) 0.86
Evaluation and planning in national tuberculosis control programmes: the usefulness of the standardised patient treatment card. East Afr Med J (1997) 0.81
An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med (2010) 4.24
The future of drug development: advancing clinical trial design. Nat Rev Drug Discov (2009) 2.68
Predictive model to identify positive tuberculosis skin test results during contact investigations. JAMA (2002) 2.53
A decision tree for tuberculosis contact investigation. Am J Respir Crit Care Med (2002) 2.25
Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat Mater (2008) 2.05
Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control (2009) 1.65
Inhibition of a background potassium channel by Gq protein alpha-subunits. Proc Natl Acad Sci U S A (2006) 1.63
Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis (2007) 1.62
Which new diagnostics for tuberculosis, and when? J Infect Dis (2012) 1.58
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. Lancet Infect Dis (2013) 1.39
Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda. PLoS Med (2008) 1.15
Voluntary counselling and testing uptake and HIV prevalence among tuberculosis patients in Jogjakarta, Indonesia. Trans R Soc Trop Med Hyg (2008) 1.14
Hemoglobin receptor in Leishmania is a hexokinase located in the flagellar pocket. J Biol Chem (2004) 1.12
A leucine-rich repeat motif of Leishmania parasite surface antigen 2 binds to macrophages through the complement receptor 3. J Immunol (2004) 1.08
Molecular differentiation of Mycobacterium tuberculosis strains without IS6110 insertions. Emerg Infect Dis (2002) 1.06
IL-6 and IL-12 specifically regulate the expression of Rab5 and Rab7 via distinct signaling pathways. EMBO J (2006) 1.04
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy. J Infect Dis (2012) 1.03
Long-term molecular analysis of tuberculosis strains in alabama, a state characterized by a largely indigenous, low-risk population. J Clin Microbiol (2005) 1.03
Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol (2007) 1.03
Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia. Am J Respir Crit Care Med (2012) 0.97
Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation. Am J Pathol (2012) 0.95
Post-operative spinal subdural extra-arachnoid hygroma causing cauda equina compression: a report of two cases. Br J Neurosurg (2011) 0.93
Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. PLoS One (2012) 0.93
Molecular typing of Mycobacterium tuberculosis strains with a common two-band IS6110 pattern. Emerg Infect Dis (2002) 0.93
Decentralization of the DOTS programme within a Russian penitentiary system. How to ensure the continuity of tuberculosis treatment in pre-trial detention centres. Eur J Public Health (2002) 0.91
Bloodstream infections among HIV-infected outpatients, Southeast Asia. Emerg Infect Dis (2010) 0.88
The relationship between bowling action classification and three-dimensional lower trunk motion in fast bowlers in cricket. J Sports Sci (2008) 0.87
Extensive drug resistance in malaria and tuberculosis. Emerg Infect Dis (2010) 0.86
Clathrin-mediated hemoglobin endocytosis is essential for survival of Leishmania. Biochim Biophys Acta (2013) 0.85
Crossed-beam slice imaging of Cl reaction dynamics with butene isomers. J Phys Chem A (2013) 0.82
Time for tuberculosis contact tracing in correctional facilities? Int J Tuberc Lung Dis (2005) 0.81
Vegetarians have a reduced skeletal muscle carnitine transport capacity. Am J Clin Nutr (2011) 0.81
GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLoS One (2011) 0.80
Tuberculosis co-morbidity and perceptions about health care among HIV-infected plasma donors in rural China. Southeast Asian J Trop Med Public Health (2009) 0.78
Robot-assisted laparoscopic radical prostatectomy in patients with prostate cancer with high-risk features: predictors of favorable pathologic outcome. J Endourol (2010) 0.78
Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response? Int J Cancer (2011) 0.78
The need for longitudinal screening studies in prison TB control. Int J Tuberc Lung Dis (2005) 0.78
Processes and outcomes of the veterans health administration safe patient handling program: study protocol. JMIR Res Protoc (2013) 0.77
Evaluating the use of gas discharge visualization to measure massage therapy outcomes. J Complement Integr Med (2015) 0.76
Childhood-onset multiple sclerosis and mood disorders: a case study. Child Neuropsychol (2004) 0.76
Adrenalectomy further suppresses the NT-3 mRNA response to traumatic brain injury but this effect is not reversed with corticosterone. Brain Res Mol Brain Res (2004) 0.76
Peripheral neurophysiology of acute distal spinal cord infarction. Pediatr Neurol (2003) 0.76
Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection. Cancer Epidemiol Biomarkers Prev (2012) 0.75
Supervision Needs Following Veteran and Service Member Moderate to Severe Traumatic Brain Injury: A VA TBI Model Systems Study. J Head Trauma Rehabil (2017) 0.75
Depletion effect of oxide semiconductor analyzed by Hall effects. J Nanosci Nanotechnol (2014) 0.75
Tunneling Characteristics Depending on Schottky Barriers and Diffusion Current in SiOC. J Nanosci Nanotechnol (2016) 0.75
Image of the month. Inverted appendix. Arch Surg (2011) 0.75
Effects of a national safe patient handling program on nursing injury incidence rates. J Nurs Adm (2014) 0.75
Dynamics of Cl + propane, butanes revisited: a crossed beam slice imaging study. Phys Chem Chem Phys (2014) 0.75